2287 results about "Glucose blood" patented technology

A method, system, and computer program product related to the diagnosis of diabetes, and is directed to predicting the long-term risk of hyperglycemia, and the long-term and short-term risks of severe hypoglycemia in diabetics, based on blood glucose readings collected by a self-monitoring blood glucose device. The method, system, and computer program product pertain directly to the enhancement of existing home blood glucose monitoring devices, by introducing an intelligent data interpretation component capable of predicting both HbA_1c and periods of increased risk of hypoglycemia, and to the enhancement of emerging continuous monitoring devices by the same features. With these predictions the diabetic can take steps to prevent the adverse consequences associated with hyperglycemia and hypoglycemia.

A method of providing performance reports to persons associated with the monitoring of an analyte level, such as blood glucose concentrations in a host, is provided. The performance reports can indicate a measure of an analyte variability of the host over a first analysis time period compared to a measure of analyte variability of the host over one or more other analysis time periods. The analyte level of the host can be received in each of a plurality of sensor readings from a continuous analyte sensor, such as multiple sensor readings per hour, so that the analyte variability that is used in determining the performance report of the host can be based on not just a few metered readings taken by the host, but a plurality of intermittent readings that are taken by a continuous analyte sensor, for example. Various types of performance reports can be generated, such as reports that comprise charts, graphs, tables, and/or other visual indicia of a host's performance during one analysis period versus another analysis period.

The present invention relates to novel peptide conjugates which have increased stability and are useful in the treatment of excess levels of blood glucose.

The invention provides nutritional supplements for an oral or enteral administration to humans, whether in satisfactory health, or having a medical condition. These supplements can provide humans with a complete, balanced nutrition in a bioavailable form, either as a food supplement or as a meal replacement, and preferably includes one or more slow-digesting carbohydrates that renders them effective in maintaining blood glucose levels at, or returning abnormal blood glucose levels to, normal blood glucose levels. Nutritional supplements within the invention can be employed with humans that are diabetic, borderline diabetic, pregnant and/or lactating, geriatric humans and humans that have, are at risk for, or develop other glucose intolerance or cardiovascular disease.

Methods and apparatus are provided for determining a diabetic patient's carbohydrate to insulin ratio (CIR), carbohydrate to blood glucose ratio (CGR), and insulin sensitivity factor (ISF) using the patient's record of blood glucose readings, carbohydrate consumption and insulin doses. The method provides the sensitivity factors that best account for the patient's observed blood glucose changes by linear regression of appropriately transformed variables. An apparatus that can collect and store the blood glucose readings, insulin dosages, and carbohydrate intake data and process these data according to this invention can generate statistically characterized sensitivity factors to advise the diabetic patient on optimal bolus insulin dosages.

A glucose monitoring kit for storing, carrying and using a blood glucose monitoring system, which includes a meter, a container for storing test strips and at least one sampler, is configured with case having two halves pivotal relative to one another, and a retention system. The retention system includes a plurality of clips arranged so that the first clip extends along the central region of the case between the two halves and second and third clips coupled to one of the halves. At least one of the first, second and third clips is made from hard polymeric material and configured to removably receive the meter so that the meter can be used by the operator of the monitoring system while being retained in the at least one clip

This invention relates to a nutritional intervention composition for enhancing satiety prior to a meal and extending satiety after a meal. The nutritional intervention composition decreases food intake producing weight loss over time. The composition consists of Niacin, Vitamin B6, Calcium, Phosphorous, Magnesium, Chromium, Chitosan, Fenugreek, Ginseng, White willow bark, Garcinia cambogia, Aloe Vera gel powder, Momordica charantia, Griffonia simplicifolia, Lagerstroemia speciosa and Vanadyl sulfate. The invention does not require stimulants or anabolic ingredients. There are three phases of activity within the composition. One, enhanced satiety through elevated serotonin. Two, improved carbohydrate metabolism, reduced blood glucose and slowed gastric emptying. Three, enhanced fiber binding of lipids and excess bile acids.

A method of glucose level control comprising providing at least one electrode adapted to apply an electric field to a pancreas; and applying an electric field to the pancreas using said at least one electrode such that blood glucose levels are significantly reduced and blood insulin levels are not significantly increased compared to a regular insulin response in a same person.

The invention relates to a Puer tea extract, a preparation method and application. The Puer tea extract contains effective ingredients of tea polyphenol, tea Polysaccharide, theabrownine, caffeine and the like the content of which are high, and can obviously lower blood sugar. The preparation method can effectively convert and dissolve out the effective ingredients. The process route can assure clarity after the cold water of a finished product is dissolved, lowers the late centrifugation workload, has low cost and stable and controllable quality and is industrial.

Monitoring system and method for use with diabetic treatment management. The system includes: a communication interface configured to permit access to stored raw log data, obtained over a certain time, being indicative of glucose measurements, meals consumed and insulin delivery; and a control unit including an unsupervised learning controller configured to receive and process said raw log data and determine at least one global insulin pump setting of basal rate, correction factor, carbohydrate ratio and insulin activity curve parameters. The system may include a processing unit including a first processor for processing measured data indicative of blood glucose level and generating first processed data, a second processor including at least one fuzzy logic module which receives input parameters corresponding to the measured data, the first processed data and a reference data, and processes the data to produce a qualitative output parameter to determine whether any treatment parameter should be modified.

The invention relates to a Pu-erh tea extract, a preparation method and application. The Pu-erh tea extract has high active ingredient content and low caffeine content, and can reduce blood sugar obviously and lower safety risks. Through the preparation method, active ingredients can be converted and dissolved out effectively. The process has the advantages of meeting the requirements of environmental protection along with simpleness, strong operability, low cost and industrialization; and the quality of the Pu-erh tea extracts is table and controllable.

The invention relates to a functional-material-based glucose biosensor. A working electrode of the glucose biosensor is made from a graphene nanomaterial, the glucose biosensor is formed by using the working electrode made from the graphene nanomaterial in the assembling of the glucose biosensor, belongs to a quantitative test technology and shows excellent linearity and resolution, and the detection sensitivity, the detection range and the detection speed are increased; and particularly in the concentration range of human blood glucose, the amplitude of a response current can be increased by 50%, and the resolution can be increased by over twice. The functional-material-based glucose biosensor and a preparation method thereof have the advantages that: immobilized enzyme of a nano-functional membrane prepared from the graphene nanomaterial can be continuously analyzed for over 1,000 times, so that the cost for measurement is low, the accuracy of analysis is higher than that of other methods, the relative error reaches about 1%, the response time is shortened to 20 seconds, the service life is also greatly prolonged, the precise timing measurement of the concentration of glucose can be achieved; and the functional-material-based glucose biosensor has the characteristics of high specificity, short-time performance, low-cost analysis, no special requirements on analyzing substances, safety and simplicity and convenience in operation, and convenience for on-site measurement and the like and can be applied to the daily measurement of blood glucose of diabetes patients.

The present invention relates to a preparation method for a copper oxide-graphene nano-complex modification glassy carbon electrode, and an application of the electrode as a glucose electrochemical sensor in rapid glucose detection, and belongs to the technical field of electrochemical analysis detection. According to the present invention, an electrochemical catalytic oxidation effect is adopted, and a current-time curve method is adopted to carry out sensitive quantitative analysis determination on the glucose, wherein the electrochemical catalytic oxidation effect is provided by the glucose sensor, and the copper oxide-graphene nano-composite material is adopted to modify the glassy carbon electrode to prepare the glucose sensor. The key point of the invention is: coating a naphthol suspension of the graphene on the surface of the treated glassy carbon electrode in a dropwise manner; carrying out open-air drying to form a layer of uniform modification layer; and adopting an electrodeposition method with a characteristic of simple operation to prepare a sensitive layer of the copper oxide-graphene nano-complex to achieve the stable catalysis of the glucose oxidation. The prepared glucose sensor of the present invention can be used clinically in detection analysis of blood glucose content in serum, and the determination process has characteristics of rapidness, sensitivity, accuracy, stability, low interference and the like.